Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis

scientific article

Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/(SICI)1097-0142(19991015)86:8<1576::AID-CNCR27>3.0.CO;2-V
P698PubMed publication ID10526288

P2093author name stringHobbs JB
Stewart JH
McCredie MR
P2860cites workUrinary tract infection and risk of bladder cancerQ71316031
The Evolution of Analgesic NephropathyQ72089482
Associations between bladder cancer risk factors and tumor stage and grade at diagnosisQ72397381
Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathyQ28277633
Observations on the effect of abolishing analgesic abuse and reducing smoking on cancers of the kidney and bladder in New South Wales, Australia, 1972-1995.Q33731115
Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymesQ38470858
Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumoursQ39579518
Unsuspected analgesic nephropathy in transitional cell carcinoma of the upper tract: a morphological studyQ40361961
Combination analgesic involvement in the pathogenesis of analgesic nephropathy: the European perspective.Q41008388
Occupation, smoking, and the risk of high-grade invasive bladder cancer in MissouriQ41124407
Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvisQ42289275
Effect of phenacetin and caffeine on N-butyl-N-(4-hydroxybutyl)-nitrosamine-initiated urothelial carcinogenesis in ratsQ43533518
Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors.Q52862067
p53 mutations in phenacetin-associated human urothelial carcinomas.Q53477903
Are the known bladder cancer risk-factors associated with more advanced bladder cancer?Q58047515
Risk factors for kidney cancer in New South Wales--I. Cigarette smokingQ67570165
Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancerQ69596727
Histologic features of bladder cancer in Boston, USA, Manchester, UK, and Nagoya, JapanQ70564031
Carcinogenicity of analgesics: long-term treatment of Sprague-Dawley rats with phenacetin, phenazone, caffeine and paracetamol (acetamidophen)Q70909480
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectpathologyQ7208
P1104number of pages7
P304page(s)1576-1582
P577publication date1999-10-01
P1433published inCancerQ326041
P1476titleMorphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis
P478volume86

Reverse relations

cites work (P2860)
Q40738932BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
Q35682594CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
Q53579655Carcinoma of the renal pelvis and ureter.
Q57565244Carcinomes urothéliaux de la voie excrétrice supérieure
Q37133629Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
Q35775984Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010.
Q30234362Epidemiology of urothelial carcinoma
Q40986079HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder
Q36563911Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
Q97527401Preintervention risk stratification of renal pelvic cancer and ureteral cancer should differ
Q37133687Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders
Q33566226Shared occupational risks for transitional cell cancer of the bladder and renal pelvis among men and women in Sweden
Q26849527Surgical management for upper urinary tract transitional cell carcinoma (UUT-TCC): a systematic review
Q80439327Synchronous bilateral ureteral and renal pelvic carcinomas: incidence, etiology, treatment and outcome

Search more.